SELLAS Life Sciences Group, Inc. (SLS)
NASDAQ: SLS · Real-Time Price · USD
1.670
-0.010 (-0.60%)
At close: Sep 16, 2025, 4:00 PM EDT
1.680
+0.010 (0.60%)
After-hours: Sep 16, 2025, 7:49 PM EDT
SLS Market Cap
SLS has a market cap or net worth of $175.85 million as of September 16, 2025. Its market cap has increased by 110.26% in one year.
Market Cap
175.85M
Enterprise Value
151.29M
1-Year Change
110.26%
Ranking
Category
Stock Price
$1.67
Market Cap Chart
Since January 2, 2018, SLS's market cap has increased from $38.66M to $175.85M, an increase of 354.81%. That is a compound annual growth rate of 21.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2025 | 176.90M | 141.68% |
| Dec 31, 2024 | 73.20M | 115.37% |
| Dec 29, 2023 | 33.99M | -30.05% |
| Dec 30, 2022 | 48.59M | -44.69% |
| Dec 31, 2021 | 87.85M | 59.80% |
| Dec 31, 2020 | 54.97M | 162.42% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jan 2, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |